Clinical Trial: Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152756) titled 'Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores' on Aug. 26.

Brief Summary: A prospective, single-center, observational study to compare the risk of gastric retention and endoscopic mucosal visibility between the exposure group (one-week discontinuation of semaglutide before EGD) and non-exposure group (no semaglutide use before EGD)

Study Start Date: Sept. 15

Study Type: OBSERVATIONAL

Condition: Gastric Retention

Intervention: PROCEDURE: Esophagogastroduodenoscopy

Assess the gastric retention and the endoscopic mucosal visibility score during esophagogastroduo...